Search research articles
Contact Us
Filters
Showing results (61-70 of 109) with videos related to
Page
of 11
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
August 4, 2023
Clinical characteristics of patients with COVID-19 harboring detectable intracellular SARS-CoV-2 RNA in peripheral blood cells
Hiromu Tanaka, Ho Namkoong, Shotaro Chubachi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 22, 2023
Characteristics and clinical effectiveness of COVID-19 vaccination in hospitalized patients in Omicron-dominated epidemic wave - a nationwide study in Japan
Hiromu Tanaka, Shotaro Chubachi, Takanori Asakura, et al.
BMC Infectious Diseases
|
May 25, 2024
Prognostic significance of chronic kidney disease and impaired renal function in Japanese patients with COVID-19
Hiromu Tanaka, Shotaro Chubachi, Takanori Asakura, et al.
The Journal of Rheumatology
|
February 3, 2015
Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort study
Hayato Yamazaki, Ryoko Sakai, Ryuji Koike, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
November 3, 2023
Prognostic significance of hypertension history and blood pressure on admission in Japanese patients with coronavirus disease 2019: integrative analysis from the Japan COVID-19 Task Force
Kaori Sakurai, Shotaro Chubachi, Takanori Asakura, et al.
Arthritis Research & Therapy
|
January 20, 2017
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial
Masako Utsunomiya, Hiroaki Dobashi, Toshio Odani, et al.
Rheumatology Advances in Practice
|
November 2, 2020
An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for <i>Pneumocystis</i> prophylaxis: results of 52-week follow-up
Masako Utsunomiya, Hiroaki Dobashi, Toshio Odani, et al.
Arthritis Care & Research
|
March 17, 2012
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis
Ryoko Sakai, Yukiko Komano, Michi Tanaka, et al.
Modern Rheumatology
|
September 20, 2017
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors
Michi Tanaka, Ryoko Sakai, Ryuji Koike, et al.
Modern Rheumatology
|
February 23, 2012
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors
Michi Tanaka, Ryoko Sakai, Ryuji Koike, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 109) with videos related to
Sort By:
Page
of 11
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
August 4, 2023
Clinical characteristics of patients with COVID-19 harboring detectable intracellular SARS-CoV-2 RNA in peripheral blood cells
Hiromu Tanaka, Ho Namkoong, Shotaro Chubachi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 22, 2023
Characteristics and clinical effectiveness of COVID-19 vaccination in hospitalized patients in Omicron-dominated epidemic wave - a nationwide study in Japan
Hiromu Tanaka, Shotaro Chubachi, Takanori Asakura, et al.
BMC Infectious Diseases
|
May 25, 2024
Prognostic significance of chronic kidney disease and impaired renal function in Japanese patients with COVID-19
Hiromu Tanaka, Shotaro Chubachi, Takanori Asakura, et al.
The Journal of Rheumatology
|
February 3, 2015
Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort study
Hayato Yamazaki, Ryoko Sakai, Ryuji Koike, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
November 3, 2023
Prognostic significance of hypertension history and blood pressure on admission in Japanese patients with coronavirus disease 2019: integrative analysis from the Japan COVID-19 Task Force
Kaori Sakurai, Shotaro Chubachi, Takanori Asakura, et al.
Arthritis Research & Therapy
|
January 20, 2017
Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial
Masako Utsunomiya, Hiroaki Dobashi, Toshio Odani, et al.
Rheumatology Advances in Practice
|
November 2, 2020
An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for <i>Pneumocystis</i> prophylaxis: results of 52-week follow-up
Masako Utsunomiya, Hiroaki Dobashi, Toshio Odani, et al.
Arthritis Care & Research
|
March 17, 2012
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis
Ryoko Sakai, Yukiko Komano, Michi Tanaka, et al.
Modern Rheumatology
|
September 20, 2017
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors
Michi Tanaka, Ryoko Sakai, Ryuji Koike, et al.
Modern Rheumatology
|
February 23, 2012
Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors
Michi Tanaka, Ryoko Sakai, Ryuji Koike, et al.
Page
of 11